Do we need PSA and early detection of prostate cancer?

Research output: Contribution to journalArticle

Standard

Do we need PSA and early detection of prostate cancer? / Abrahamsson, Per-Anders; Tinzi, Martina.

In: European Urology. Supplement, Vol. 7, No. 5, 2008, p. 393-395.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

Abrahamsson, Per-Anders ; Tinzi, Martina. / Do we need PSA and early detection of prostate cancer?. In: European Urology. Supplement. 2008 ; Vol. 7, No. 5. pp. 393-395.

RIS

TY - JOUR

T1 - Do we need PSA and early detection of prostate cancer?

AU - Abrahamsson, Per-Anders

AU - Tinzi, Martina

PY - 2008

Y1 - 2008

N2 - The limitations of PSA as a screening marker for diagnosis and prostate cancer treatment are well known. The low specificity of PSA results in many unnecessary prostate biopsies, furthermore high rates of over-detection and overtreatment affect patients' quality of life. New assays measuring different molecular forms of PSA have resulted only in a moderate improvement of specificity especially beyond the PSA range of 2 to 10 ng/ml. Novel biomarkers for prostate cancer detection are emerging and they might enable clinicians to differentiate indolent from aggressive cancers in order to minimize overtreatment in future. (c) 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.

AB - The limitations of PSA as a screening marker for diagnosis and prostate cancer treatment are well known. The low specificity of PSA results in many unnecessary prostate biopsies, furthermore high rates of over-detection and overtreatment affect patients' quality of life. New assays measuring different molecular forms of PSA have resulted only in a moderate improvement of specificity especially beyond the PSA range of 2 to 10 ng/ml. Novel biomarkers for prostate cancer detection are emerging and they might enable clinicians to differentiate indolent from aggressive cancers in order to minimize overtreatment in future. (c) 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.

KW - biomarkers

KW - prostate cancer detection

KW - PSA

KW - screening

U2 - 10.1016/j.eursup.2008.01.018

DO - 10.1016/j.eursup.2008.01.018

M3 - Article

VL - 7

SP - 393

EP - 395

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

IS - 5

ER -